Ivermectin as a potential treatment for mild to moderate COVID-19 – A double blind randomized placebo-controlled trial
bioRxiv (2021) - Comments
doi: 10.1101/2021.01.05.21249310 

Ravi Kirti, Ranjini Roy, Chandrima Pattadar, Rishav Raj, Neeraj Agarwal, Bijit Biswas, Pramod Kumar Manjhi, Deependra Kumar Rai, Shyama Shyama, Anjani Kumar, Asim Sarfaraz